Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 165,000 |
|
|||||
| News | - | ||||||
| Day High | 2.7899 | Low High |
|||||
| Day Low | 2.4601 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Path Holdings Inc | BPTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.235 | -8.75% | 2.45 | 19:43:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.65 | 2.4601 | 2.7899 | 2.49 | 2.685 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,180 | 165,000 | $ 2.59 | $ 426,792 | - | 2.4601 - 44.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:36:02 | 58 | $ 2.40 | USD |
Bio Path Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.69M | 678.80k | - | 0 | -16.08M | -23.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bio Path News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BPTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.12 | 7.6699 | 2.4601 | 4.18 | 17,404,772 | -0.67 | -21.47% |
| 1 Month | 4.14 | 7.6699 | 2.4601 | 4.17 | 4,603,504 | -1.69 | -40.82% |
| 3 Months | 8.22 | 9.9875 | 2.4601 | 4.31 | 1,572,665 | -5.77 | -70.19% |
| 6 Months | 12.504 | 14.424 | 2.4601 | 5.03 | 812,324 | -10.05 | -80.41% |
| 1 Year | 28.00 | 44.80 | 2.4601 | 10.66 | 1,152,050 | -25.55 | -91.25% |
| 3 Years | 123.00 | 172.398 | 2.4601 | 40.18 | 528,048 | -120.55 | -98.01% |
| 5 Years | 362.00 | 486.80 | 2.4601 | 93.08 | 526,906 | -359.55 | -99.32% |
Bio Path Description
| Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003. |
